SCHEMBL14921065

SCHEMBL14921065

CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ C5AR1 P21730 2/20 0.49
▸ CTSL P07711 3/20 0.46
▸ CTSS P25774 3/20 0.46
▸ CTSK P43235 3/20 0.46
▸ CTSH P09668 1/20 0.46
▸ MC4R P32245 1/20 0.46
▸ OPRM1 P35372 6/20 0.46
▸ OPRK1 P41145 6/20 0.46
▸ CXCR4 P61073 1/20 0.45
▸ NTSR2 O95665 1/20 0.44
▸ NTSR1 P30989 1/20 0.44
▸ SORT1 Q99523 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16212659 0.94 C5AR1 (0.54) C5AR1CTSLCTSSCTSKCTSH
SCHEMBL30901130 0.91 AGTR1 (0.49) C5AR1CTSLCTSSCTSKCTSH
SCHEMBL29608024 0.89 C5AR1 (0.57) C5AR1MC4ROPRM1OPRK1CXCR4
SCHEMBL29608116 0.89 C5AR1 (0.57) C5AR1MC4ROPRM1OPRK1CXCR4
SCHEMBL30504860 0.89 C5AR1 (0.52) C5AR1CTSLCTSSCTSKCTSH
SCHEMBL29607839 0.89 C5AR1 (0.56) C5AR1MC4ROPRM1OPRK1CXCR4
SCHEMBL31409175 0.88 C5AR1 (0.53) C5AR1NTSR2NTSR1SORT1
SCHEMBL30901125 0.88 AGTR2 (0.47) C5AR1CTSLCTSSCTSKCTSH
SCHEMBL30230017 0.88 OPRM1 (0.58) CTSLCTSSCTSKCTSHOPRM1
SCHEMBL30272476 0.88 NTSR1 (0.46) C5AR1MC4RNTSR2NTSR1SORT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109806395-A Medical usage 瓦力雷克斯有限公司 2019-05-28 — — CN claimed
CN-104136082-B medical use 瓦力雷克斯有限公司 2019-03-08 — — CN claimed
EP-2773427-A2 MEDICAL USE Valirx Plc. (GB) 2014-09-10 — — EP claimed
WO-2013064830-A2 MEDICAL USE VALIRX PLC (GB) 2013-05-10 — — WO claimed
Send feedback